Open access
Aug 2026
Efficacy of erythropoietin-stimulating medications in controlling anemia in CKD patients
Iron deficiency, chronic inflammation, and decreased endogenous erythropoietin production are the main causes of anemia, a prevalent and crippling consequence of chronic kidney disease (CKD). To raise hemoglobin levels, lower the requirement for blood transfusions, and improve patient quality of life, erythropoietin-st...
Londa Eswar Naga Sai Datta Yadav, S. Pooja, Matta Purna Rajeena et al.
· Journal of medical pharmaceu... · 0 citations